Calvenza -03 EIV/EHV - Single Dose Syringe

For the vaccination of healthy, susceptible horses 6 months of age or older, including pregnant mares, as an aid in the reduction of respiratory diseases caused by equine herpes virus type I (EHV-!) and type 4 (EHV-4), and by equine influenza virus types A2 North American and A2 Eurasian. Inoculate horses intramuscularly with a 2ml dose. Administer a second 2 ml dose intramuscularly in 3-4 weeks using a different injection site. Administer a third 2 ml dose in 3-4 weeks by either intramuscular injection or intranasal route. Revaccinate annually.

Differs from original calvenza because the Ohio/2006(H3N8) equine influenza strain was added and the new market/77(H7N7) strain was removed.